What Patients Should Know Before Stopping or Starting a GLP-1 More research is needed on strategies to prevent weight regain after ceasing medication, says Dr
Key quality indicators include: the pharmacy conducts in-house stability testing on their specific formulations, they perform sterility testing on each batch, they follow USP 797 guidelines for sterile compounding, and they can provide certificates of analysis upon request
Rybelsus (PIONEER Trials - Oral) The PIONEER program was designed to evaluate the efficacy and safety of Rybelsus, the first-of-its-kind oral formulation of a GLP-1 RA
The metabolic, endocrine, cardiovascular, nervous, and reproductive systems all face daily obstacles that prevent them from functioning optimally
The study involved 338 adults with obesity (no diabetes) and compared weekly Retatrutide injections against placebo over 48 weeks